Through our unwavering commitment to patients and through the love of family and friends, nature and people, we relentlessly continue to push the boundaries of medicine with the aim of bettering people's lives.1
Get full access to this article
View all access options for this article.
References
1.
OrlandoGLerutJPSokerSStrattaRJ, eds. Editors dedication. In: Regenerative Medicine Applications in Organ Transplantation. New York, NY: Elsevier; 2013.
2.
TisoneGOrlandoGCardilloA. Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favorably impacts on the progression of disease recurrence. J Hepatol. 2006;44(4):702–709.
3.
AtalaABauerSBSokerSYooJJRetikAB. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet. 2006;367(9518):1241–1246.
4.
OrlandoGSokerSStrattaRJ. Organ bioengineering and regeneration as the new Holy Grail of organ transplantation. Ann Surg. 2013;258(2):221–232.
5.
KatariRPelosoAZambonJPOrlandoG. Sysyphus, the Giffen paradox and the Holy Grail: time for organ transplantation to transition towards a regenerative medicine-focused type of research. Exp Rev Clin Immunol. 2013;9:883–885.
6.
OrlandoGWoodKJStrattaRJYooJAtalaASokerS. Regenerative medicine and organ transplantation: past, present and future. Transplantation. 2011;91:1310–1317.
7.
PelosoAKatariRMurphySV. Prospect for kidney bioengineering: shortcomings of the status quo. Expert Opin Biol Ther. 2015;15(4):547–558.
8.
OrlandoGWalkerSJ. Organ bioengineering, regeneration and repair: where the future of organ transplantation is taking shape. J Transplant Stem Cel Biol. 2014;1(2):1–2.
